Michael Keese
Overview
Explore the profile of Michael Keese including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
He Z, Starkuviene V, Keese M
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941329
Mesenchymal stem cells (MSCs) are a family of multipotent stem cells that show self-renewal under proliferation, multilineage differentiation, immunomodulation, and trophic function. Thus, these cells, such as adipose tissue-derived mesenchymal...
2.
Yagublu V, Bayramov B, Reissfelder C, Hajibabazade J, Abdulrahimli S, Keese M
Clin Exp Metastasis
. 2024 Apr;
41(5):707-715.
PMID: 38609535
Chemotherapy drugs efficiently eradicate rapidly dividing differentiated cells by inducing cell death, but poorly target slowly dividing cells, including cancer stem cells and dormant cancer cells, in the later course...
3.
Aslanov H, Bayramov B, Reissfelder C, Abdullayeva S, Mammadova Z, Aliyev F, et al.
J Clin Med
. 2024 Jan;
13(1).
PMID: 38202226
Background: Understanding the relationships between the methylenetetrahydrofolate reductase () gene polymorphism, colorectal polyps, and CRC risk can aid in advancing personalized medicine approaches in CRC prevention. The aim of the...
4.
Keese M, Zheng J, Yan K, Bieback K, Yard B, Pallavi P, et al.
Int J Mol Sci
. 2023 Dec;
24(24).
PMID: 38139026
Adipose-derived stem cells (ASCs) have been used as a therapeutic intervention for peripheral artery disease (PAD) in clinical trials. To further explore the therapeutic mechanism of these mesenchymal multipotent stromal/stem...
5.
Gerken A, Hattemer M, Weiss C, Sigl M, Zach S, Keese M, et al.
J Vasc Nurs
. 2023 Dec;
41(4):212-218.
PMID: 38072575
Objective: The use of medical compression stockings (MCS) in patients with peripheral arterial disease (PAD) and diabetes is the subject of an ongoing critical debate. While reducing leg edema of...
6.
Shao J, Zhou Q, Jin F, Reissfelder C, Sigl M, Yagublu V, et al.
J Clin Med
. 2023 Dec;
12(23).
PMID: 38068502
Background: Postthrombotic syndrome (PTS) has a major impact on the quality of life after deep venous thrombosis (DVT). From clinical practice and related trials, anticoagulants show potential for reducing the...
7.
Sigl M, Baumann S, Konemann A, Keese M, Schwenke K, Gerken A, et al.
Herz
. 2023 Oct;
49(3):210-218.
PMID: 37789149
Background: Major vascular surgery is associated with a high perioperative risk and significant mortality. Despite advances in risk stratification, monitoring, and management of perioperative complications, cardiac complications are still common....
8.
Guo F, Kan K, Ruckert F, Ruckert W, Li L, Eberhard J, et al.
Int J Mol Sci
. 2023 Sep;
24(17).
PMID: 37686338
There is an ongoing need for patient-specific chemotherapy for pancreatic cancer. Tumour cells isolated from human tissues can be used to predict patients' response to chemotherapy. However, the isolation and...
9.
Li L, Zeng Z, Yagublu V, Rahbari N, Reissfelder C, Keese M
J Pers Med
. 2023 Jun;
13(6).
PMID: 37373979
Aortic dissection (AD) is a life-threatening cardiovascular disease. Pathophysiologically, it has been shown that aortic wall inflammation promotes the occurrence and development of aortic dissection. Thus, the aim of the...
10.
Yan K, Zheng J, Kluth M, Li L, Ganss C, Yard B, et al.
Stem Cell Res Ther
. 2023 Feb;
14(1):24.
PMID: 36759868
Background: Hypoxia in ischemic disease impairs Ca homeostasis and may promote angiogenesis. The therapeutic efficacy of mesenchymal stromal cells (MSCs) in peripheral arterial occlusive disease is well established, yet its...